Ciprofloxacin and trimethoprim cause phage induction and virulence modulation in Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 1, 2006, Pages 171-177

  Goerke, Christiane ^a   Koller, Johanna ^a   Wolz, Christiane ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ENTEROTOXIN; HEMOLYSIN; MITOMYCIN C; STAPHYLOKINASE; TRIMETHOPRIM; VIRULENCE FACTOR;

ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIOPHAGE; BACTERIUM ISOLATE; CYSTIC FIBROSIS; DOSE RESPONSE; DRUG EFFECT; GENETIC CODE; GENETIC TRANSCRIPTION; LUNG INFECTION; LYSOGENIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECA GENE; STAPHYLOCOCCUS AUREUS;

BACTERIAL TOXINS; CIPROFLOXACIN; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, VIRAL; HEMOLYSIN PROTEINS; LYSOGENY; MICROBIAL SENSITIVITY TESTS; SOS RESPONSE (GENETICS); SPHINGOMYELIN PHOSPHODIESTERASE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGES; TRIMETHOPRIM; VIRULENCE;

EID: 29944432382     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.1.171-177.2006     Document Type: Article

References (28)

1. Arvidson, S. 1983. Extracellular enzymes from Staphylococcus aureus, p. 745-808. In: C. F. Easmon and C. Adlam (ed.), Staphylococci and staphylococcal infections. Academic Press, London, United Kingdom.
2. Baba, T., F. Takeuchi, M. Kuroda, H. Yuzawa, K. Aoki, A. Oguchi, Y. Nagai, N. Iwama, K. Asano, T. Naimi, H. Kuroda, L. Cui, K. Yamamoto, and K. Hiramatsu. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819-1827.
3. Betley, M. J., and J. J. Mekalanos. 1985. Staphylococcal enterotoxin A is encoded by phage. Science 229:185-187.
4. Bisognano, C., W. L. Kelley, T. Estoppey, P. Francois, J. Schrenzel, D. Li, D. P. Lew, D. C. Hooper, A. L. Cheung, and P. Vaudaux. 2004. A recA-lexA-dependent pathway mediates ciprofloxacin-induced fibronectin binding in Staphylococcus aureus. J. Biol. Chem. 279:9064-9071.
5. Coleman, D. C., D. J. Sullivan, R. J. Russell, J. P. Arbuthnott, B. F. Carey, and H. M. Pomeroy. 1989. Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of beta-lysin, staphylokinase and enterotoxin A: molecular mechanism of triple conversion. J. Gen. Microbiol. 135:1679-1697.
6. Goerke, C., S. Campana, M. G. Bayer, G. Döring, K. Botzenhart, and C. Wolz. 2000. Direct quantitative transcript analysis of the agr regulon of Staphvlococcus aureus during human infection in comparison to the expression profile in vitro. Infect. Immun. 68:1304-1311.
7. Goerke, C., K. Kraning, M. Stern, G. Döring, K. Botzenhart, and C. Wolz. 2000. Molecular epidemiology of community-aquircd Staphylococcus aureus in families with and without cystic fibrosis patients. J. Infect. Dis. 181:984-989.
8. Goerke, C., S. Matias y Papenberg, S. Dasbach, K. Dietz, R. Ziebach, B. C. Kahl, and C. Wolz. 2004. Increased frequency of genomic alterations in Staphvlococcus aureus during chronic infection is in part due to phage mobilization. J. Infect. Dis. 189:724-734.
9. Holden, M. T., E. J. Feil, J. A. Lindsay, S. J. Peacock, N. P. Day, M. C. Enright, T. J. Foster, C. E. Moore, L. Hurst, R. Atkin, A. Barron, N. Bason, S. D. Bentley, C. Chillingworth, T. Chillingworth, C. Churcher, L. Clark, C. Corton, A. Cronin, J. Doggett, L. Dowd, T. Feltwell, Z. Hance, B. Harris, H. Hauser, S. Holroyd, K. Jagels, K. D. James, N. Lennard, A. Line, R. Mayes, S. Moule, K. Mungall, D. Orraond, M. A. Quail, E. Rabbinowitsch, K. Rutherford, M. Sanders, S. Sharp, M. Siraraonds, K. Stevens, S. Whitehead, B. G. Barrell, B. G. Spratt, and J. Parkhill. 2004. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. USA 101:9786-9791.
10. Iandolo, J. J., V. Worrell, K. H. Groicher, Y. Qian, R. Tian, S. Kenton, A. Dorraan, H. Ji, S. Lin, P. Loh, S. Qi, H. Zhu, and B. A. Roe. 2002. Comparative analysis of the genomes of the temperate bacteriophages phi 11, phi 12 and phi 13 of Staphylococcus aureus 8325. Gene 289:109-118.
11. Jin, T., M. Bokarewa, T. Foster, J. Mitchell, J. Higgins, and A. Tarkowski. 2004. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol. 172:1169-1176.
12. Kaneko, J., T. Kimura, S. Narita, T. Tornita, and Y. Karaio. 1998. Complete nucleotide sequence and molecular characterization of the temperate Staphylococcal bacteriophage phiPVL carrying Panton-Valentine leukocidin genes. Gene 215:57-67.
13. Kuroda, M., T. Ohta, I. Uchiyama, T. Baba, H. Yuzawa, I. Kobayashi, L. Cui, A. Oguchi, K. Aoki, Y. Nagai, J. Lian, T. Ho, M. Kanamori, H. Matsuraaru, A. Maruyaraa, H. Murakami, A. Hosoyaraa, Y. Mizutani-Ui, N. K. Takahashi, T. Sawano, R. Inoue, C. Kaito, K. Sekimizu, H. Hirakawa, S. Kuhara, S. Goto, J. Yabuzaki, M. Kanehisa, A. Yaraashita, K. Oshima, K. Furuya, C. Yoshino, T. Shiba, M. Hattori, N. Ogasawara, H. Hayashi, and K. Hiramatsu. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.
14. Lindsay, J. A., A. Ruzin, H. F. Ross, N. Kurepina, and R. P. Novick. 1998. The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol. Microbiol. 29:527-543.
15. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-532.
16. Lunde, M., J. M. Blatny, D. Lillehaug, A. H. Aastveit, and I. F. Nes. 2003. Use of real-time quantitative PCR for the analysis of phiLC3 prophage stability in laetoeocci. Appl. Environ. Mierobiol. 69:41-48.
17. Mei, J. M., F. Nourbakhsh, C. W. Ford, and D. W. Holden. 1997. Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis. Mol. Microbiol. 26:399-407.
18. IS. Narita, S., J. Kaneko, J. Chiba, Y. Piemont, S. Jarraud, J. Etienne, and Y. Kamio. 2001. Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT. Gene 268:195-206.
19. Novick, R. P. 2003. Mobile genetic elements and bacterial toxinoses: the superantigen-encoding pathogenicity islands of Staphylococcus aureus. Plasmid 49:93-105.
20. Ptashne, M. 1992. A genetic switch. Cell Press, Cambridge, Mass.
21. Sumby, P., and M. K. Waldor. 2003. Transcription of the toxin genes present within the staphylococcal phage φSa3ms is intimately linked with the phage's life cycle. J. Bacteriol. 185:6841-6851.
22. Ubeda, C., E. Maiques, E. Knecht, I. Lasa, R. P. Novick, and J. R. Penades. 2005. Antibiotic-induced SOS response promotes horizontal dissemination of pathogenicity island-encoded virulence factors in staphylococci. Mol. Microbiol. 56:836-844.
23. Wagner, P. L., J. Livny, M. N. Neely, D. W. Acheson, D. I. Friedman, and M. K. Waldor. 2002. Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol. Microbiol. 44:957-970.
24. Wagner, P. L., and M. K. Waldor. 2002. Bacteriophage control of bacterial virulence. Infect. Immun. 70:3985-3993.
25. Walker, C. W. 1996. The SOS response of Escherichia coli, p. 1400-1416. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. Brooks Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and E. H. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology. ASM Press, Washington, D.C.
26. Yamaguchi, T., T. Hayashi, H. Takarai, K. Nakasone, M. Ohnishi, K. Nakayarama, S. Yaraada, H. Komatsuzawa, and M. Sugai. 2000. Phage conversion of exfoliative toxin A production in Staphylococcus aureus. Mol. Microbiol. 38:694-705.
27. Zhang, X., A. D. McDaniel, L. E. Wolf, G. T. Keusch, M. K. Waldor, and D. W. Acheson. 2000. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 181:664-670.
28. Ziebuhr, W., K. Dietrich, M. Trautmann, and M. Wilhelm. 2000. Chromosomal rearrangements affecting biofilm production and antibiotic resistance in a Staphylococcus epidemidis strain causing shunt-associated ventriculitis. Int. J. Med. Microbiol. 290:115-120.